Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:appears_in |
multiple cities in China
|
| gptkbp:collaborated_with |
academic institutions
|
| gptkbp:collaborates_with |
local healthcare providers
|
| gptkbp:contributed_to |
research and development
|
| gptkbp:develops |
therapeutic solutions
|
| gptkbp:employs |
thousands of people
|
| gptkbp:engages_in |
clinical trials
|
| gptkbp:established |
gptkb:1993
|
| gptkbp:focuses_on |
innovation
biopharmaceuticals biotechnology advancements affordable healthcare |
| gptkbp:has_achievements |
regulatory approvals
|
| gptkbp:headquartered_in |
gptkb:China
|
| https://www.w3.org/2000/01/rdf-schema#label |
Astra Zeneca China
|
| gptkbp:investment |
local communities
|
| gptkbp:is_active_in |
digital health initiatives
|
| gptkbp:is_committed_to |
patient safety
|
| gptkbp:is_engaged_in |
patient advocacy
|
| gptkbp:is_involved_in |
sustainability efforts
vaccine distribution healthcare policy advocacy |
| gptkbp:is_known_for |
gptkb:drug
|
| gptkbp:is_part_of |
clinical research networks
global healthcare system |
| gptkbp:is_recognized_for |
corporate social responsibility
quality standards |
| gptkbp:is_supported_by |
global research teams
|
| gptkbp:offers |
vaccines
diabetes medications |
| gptkbp:operates |
manufacturing facilities
|
| gptkbp:part_of |
gptkb:temple
|
| gptkbp:participates_in |
healthcare conferences
|
| gptkbp:partnership |
government agencies
|
| gptkbp:partnerships |
NG Os
|
| gptkbp:produced_by |
oncology drugs
cardiovascular drugs respiratory drugs |
| gptkbp:provides |
gptkb:Educational_Institution
healthcare solutions |
| gptkbp:research_focus |
rare diseases
|
| gptkbp:strategic_importance |
expansion in Asia
|
| gptkbp:supports |
public health initiatives
|
| gptkbp:bfsParent |
gptkb:Astra_Zeneca_Pharmaceuticals_LP
|
| gptkbp:bfsLayer |
4
|